/
DRA. Adriana Teixeira rodrigues DRA. Adriana Teixeira rodrigues

DRA. Adriana Teixeira rodrigues - PowerPoint Presentation

pagi
pagi . @pagi
Follow
346 views
Uploaded On 2022-02-15

DRA. Adriana Teixeira rodrigues - PPT Presentation

Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome 兒童和青少年自身免疫性肝炎和重疊綜合徵的臨床特徵和預後 ID: 909181

autoimmune aih children hepatitis aih autoimmune hepatitis children clinical patients diagnosis overlap criteria adolescents ggt day syndrome treatment characteristics

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "DRA. Adriana Teixeira rodrigues" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

DRA. Adriana Teixeira rodrigues

Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome 兒童和青少年自身免疫性肝炎和重疊綜合徵的臨床特徵和預後

Slide2

Slide3

Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome

兒童和青少年自身免疫性肝炎和重疊綜合徵的臨床特徵和預後

AUTOIMMUNE HEPATITIS

134

children and adolescents

diagnosis of autoimmune hepatitis (AIH

),

January 1986 to March 2014.

(

134

例自身免疫性肝炎(

AIH

)診斷為兒童和青少年的隊列研究,從

1986

1

月至

2014

3

月出現。

)

Slide4

Brief introductionAutoimmune hepatitis (AIH):rare in childhood (incidence ~0.4 / 100,000)chronic inflammation,hypergammaglobulinemia,presence of circulating autoantibodies,

presence of other autoimmune conditions in the patient or their close relatives;good response to treatment.

Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome

兒童和青少年自身免疫性肝炎和重疊綜合徵的臨床特徵和預後

Slide5

AIH: clinical presentation The clinical presentation is varied, being justified his research in all the patients with acute or chronic hepatitis without determinate cause.

Presentation:Acute hepatitisChronic hepatitisFulminant hepatic failure

Silent or asymptomatic

It

is more frequent in the female gender.

Slide6

AIH: typesAIH type 1: anti-nuclear antibody (ANA) or smooth muscle antibody (SMA),or anti-actin antibody (AAA).

AIH type 2 (HAI-2): antibodies to liver-kidney microsome type 1 (anti-LKM1) and/or anti-bodies to liver cytosol type 1 (anti-LC1).ALVAREZ et al., 1999; MIELI-VERGANI, VERGANI, 2009; FERRI et al., 2012.

Slide7

AIH: diagnosisDiagnosis:It is based on the following parameters

1) Histology;2) Autoantibody titers;3) IgG or gammaglobulin level, and4) Absence of viral hepatitis

Diagnostic criteria, 1993 (JOHNSON,

McFARLANE

, 1993).

Criteria reviewed, 1998 (ALVAREZ et al., 1999)

Simplified criteria (HENNES et al., 2008)

Slide8

AIH: diagnosis There was no morphological pathognomonic finding. It is suggestive "the presence of

interface hepatitis, necroinflammatory lymphoplasmacytic infiltration, hepatic rosette formation and nodular regeneration in severe cases "(ALVAREZ et al., 1999)

Slide9

Criteria for diagnosis of autoimmune hepatitisJOHNSON P. J.; McFARLANE

, Ian G. Meeting Report: International Autoimmune Hepatitis Group. Hepatology, v.18, n.4, p. 998-1005, out., 1993.ALVAREZ, Fernando et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

.

Journal

of

Hepatology

, v. 31, p 929-938, 1999.

HENNES,

Elke

M

et al

. Simplified Criteria for the Diagnosis of Autoimmune Hepatitis.

Hepatology

, v. 48, n. 1,

jul.

, 2008.

Slide10

AIH: Simplified Diagnostic Criteria forAutoimmune Hepatitis in Children

2008 diagnostic criteria for AIH: excellent sensitivity and specificity

Except in those AIH patients with FHF.

Recommended in this case the 1999 system.

Cholangiographic

studies should be performed in all children with AIH to exclude PSC.

Serum globulin levels and IgG can be used interchangeably

ELIZABETH MILETI, PHILIP ROSENTHAL, and MARION G. PETERS. Validation and Modification of Simplified Diagnostic Criteria for Autoimmune Hepatitis in Children. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2012;10:417– 421

Slide11

Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap SyndromeAutoimmune sclerosing cholangitis (ASC):

Those patients who presented increased levels of gamma glutamyl transferase (GGT) and/or poor response to immunosuppressive treatment were referred for magnetic resonance imaging (MRI) of the biliary tract. The diagnosis of ASC was established when the MRI showed the presence of abnormalities in the biliary tract

, such as stenosis and/or dilatation of the intra- and/ or

extrahepatic

ducts.

Slide12

AIH: treatment protocol prednisone and azathioprine: 1 to 2 mg / kg / day (maximum 60 mg / day) and 1.5 mg / kg / day (maximum 100 mg / day), respectively.

Prednisone was reduced by 10 mg every two weeks until a dose of 20 mg / day, when it was reduced from 5 mg every two months to 5 mg every other day, keeping the patient in clinical-laboratory remission. Azathioprine was maintained at the initial dose, unless leukopenia or thrombocytopenia were present.

Ursodeoxycholic

acid

was associated with treatment in suspected cases of association with autoimmune cholangitis: 15 to 20 mg / kg / day.

Slide13

Medication withdrawal Patients with type 1 AIH (ANA and / or AML positive)complete response to treatment,

clinical and laboratory remission time of at least 24 months, no inflammatory activity in the histopathology hepatic. The drug suspension schedule: prednisone 25% reduction in maintenance dose (5 mg / day) every 7 days; azathioprine - its suspension is initiated after the suspension of prednisone; in the beginning, it is halved and completed one month later.

Clinical and laboratory evaluation every two months after discontinuation of the medication.

Considered reactivation:

clinical manifestations suggestive of the disease,

elevation of aminotransferases,

gammaglobulin

fraction, and autoantibodies reappearance

.

The change in any of these parameters is reason for reintroduction of the treatment.

Slide14

Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome

Cohort study of 134 children and adolescents with a known diagnosis of autoimmune hepatitis (AIH), attended from January 1986 to March 2014.

(

134

例自身免疫性肝炎(

AIH

)診斷為兒童和青少年的隊列研究,從

1986

1

月至

2014

3

月出現。

)

First studies:

1996

(

28 children

) and all patients have their data updated, even after they turn 18, to this time.

第一次研究:

1996

年(

28

名兒童),所有患者的數據在

18

歲之後即更新

Slide15

First studies: 1996First studies: 1996 (28 children

)

Slide16

Other studies

Proper treatment improves the prognosis and reduces the formation of fibrosis and progression to cirrhosis in patients with AIH.

Slide17

Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome

HEPATOLOGY Vol. 33, No. 3, 2001This was special because those children like ours was first diagnosed with AIH.

Slide18

Autoimmune sclerosing cholangitis (ASC).

During follow-up, some of those 134 children with IAH developed autoimmune sclerosing cholangitis (ASC). 在隨訪期間,其中一些發展為自身免疫性硬化性膽管炎Suspected diagnosis: increased levels of GGT and/or

poor response to immunosuppressive treatment

The diagnosis of ASC was

established

when the MRI showed the presence of

abnormalities in the biliary tract

, such as stenosis and/or dilatation of the intra- and/ or

extrahepatic

ducts.

Slide19

ResultsThe baseline clinical characteristics

Slide20

Comparison between groups concerning the laboratory parameters at baseline

Slide21

RESULTS: GGT

Those patients whose

GGT level increased during follow-up

period, however,

had the diagnosis of overlap syndrome more often

than those whose GGT level remained normal (

P

=

0.018).

It was also observed that

none

of the

patients whose GGT values were normal or rose up to 1.5 times

the upper normal limit at baseline

developed ASC

(

P

<

0.017).

Slide22

RESULTS: follow-up

Slide23

Survival probability

Slide24

Discussion - conclusionFemale gender: AIH >AIH/SC

GGT normal: AIH INCREASED GGT => AIH~AIH/SCTime at remission: AIH >AIH/SCRelapse more often AIH/SCTransplantation AIH ~AIH/SC (16 patients)Mortality AIH ~AIH/SC Bigger impact in mortality: cirrhosis (68%);

Gregorio

et al

found a 15% prevalence of cirrhosis in patients with overlap syndrome, compared with 23% in patients with AIH

(Gregorio GV, Portmann B, Karani J, et al. Autoimmune hepatitis/

sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective

study

.

Hepatology

2001;33:544–53).

.

Slide25

Thank you! 謝謝

Slide26

Belo Horizonte - Brazil